European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™
Key facts
- Where
- Hamburg and Münster, GermanySee the 2 sites
Where in Germany
- ASKLEPIOS Kliniken St. GeorgHamburg, GermanyContact: Prof. Dr. med.Taking people
- Universitätsklinikum Münster (UKM)Münster, GermanyContact: Jana EbingTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
- Trial code
- NCT07668687
- Record updated
- 25 June 2026
- Original description
The Castor™ and Cratos™ Branched Aortic Stent Graft Systems are medical devices designed for the minimally invasive endovascular treatment of thoracic aortic pathologies in the descending aorta. The goal of this multi-centre retrospective and prospective observational registry study is to capture the short-, medium- to long-term safety and performance data of how Castor™ and Cratos™ stent-grafts work in real-world settings (everyday medical practice). The aim is to study approximately 100 patients in European hospitals, with competitive enrollment.Read full original descriptionShow less
European Multi-Centre Castor™ and Cratos™ Branched Endovascular Arch Repair Registry
The Castor™ and Cratos™ Branched Aortic Stent Graft Systems are medical devices designed for the minimally invasive endovascular treatment of thoracic aortic pathologies in the descending aorta. The goal of this multi-centre retrospective and prospective observational registry study is to capture the short-, medium- to long-term safety and performance data of how Castor™ and Cratos™ stent-grafts work in real-world settings (everyday medical practice). The aim is to study approximately 100 patients in European hospitals, with competitive enrollment.
Inclusion: Implantation of a Castor™ or Cratos™ single branch endoprothesis with incorporation of the left subclavian artery; Age >18 years.
Exclusion: Patients allergic to the materials of the device; Patients with severe or potentially systemic infections that increase the chance of graft infection; Minors and pregnant women; Branch for other supra-aortic vessels than the LSA; Rejection of participation.